FEI (FEIC), Covidien plc (COV), China XD Plastics (CXDC), The Dow Chemical Company (DOW), Enterprise Products Partners (EPD), Energy XXI (EXXI) and Fossil (FOSL) ratings and price targets updates from analysts.
Goldman Sachs (NYSE:GS) reiterated its “Buy” rating on Covidien plc (COV).
Oppenheimer reiterated its “Outperform” rating on China XD Plastics (CXDC). They have a price target of $7.00 on the company.
Morgan Stanley (NYSE:MS) initiated coverage on The Dow Chemical Company (DOW). They placed an “Equal Weight” rating and a price target of $35.00 on the company.
Oppenheimer reiterated its “Outperform” rating on Enterprise Products Partners (EPD). They have a price target of $47.00 on the company.
Rodman & Renshaw reiterated its “Outperform” on Energy XXI (EXXI). They have a price target of $35.00 on the company.
Needham & Company raised its price target on FEI (FEIC) from $43.00 to $47.00. They have a “Buy” rating on the company.
Piper Jaffray (NYSE:PJC) reiterated its “Overweight” rating on Fossil (FOSL).
Thursday, November 17, 2011
FEI (FEIC) (COV) (CXDC) (DOW) (EPD) (EXXI) (FOSL) Ratings, Price Targets
Labels:
Dow Chemical,
Goldman Sachs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment